The Krüppel-like protein Gli-similar 3 (Glis3) functions as a key regulator of insulin transcription

Molecular Endocrinology

Volumn 27, Issue 10, 2013, Pages 1692-1705

  ZeRuth, Gary T ^a   Takeda, Yukimasa ^a   Jetten, Anton M ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; GLI SIMILAR 3 PROTEIN; INSULIN; KRUPPEL LIKE FACTOR; NEUROGENIC DIFFERENTIATION FACTOR; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR MAFA; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONTROLLED STUDY; DIABETES MELLITUS; ENHANCER REGION; HUMAN; HUMAN CELL; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RAT; TRANSACTIVATION; TRANSCRIPTION REGULATION; ZINC FINGER MOTIF;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BINDING SITES; CELL LINE, TUMOR; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; INSULIN; MAF TRANSCRIPTION FACTORS, LARGE; MEMBRANE PROTEINS; MICE; NERVE TISSUE PROTEINS; PHOSPHOPROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RATS; REPRESSOR PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84884765608     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2013-1117     Document Type: Article

References (45)

1. Kang HS, ZeRuth G, Lichti-Kaiser K, et al. Gli-similar (Glis) Krüppel-like zinc finger proteins: insights into their physiological functions and critical roles in neonatal diabetes and cystic renal disease. Histol Histopathol. 2010;25:1481-1496.
2. Lichti-Kaiser K, ZeRuth G, Kang HS, Vasanth S, Jetten AM. Glisimilar proteins: their mechanisms of action, physiological functions, and roles in disease. Vitam Horm. 2012;88:141-171.
3. Senée V, Chelala C, Duchatelet S, et al. Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat Genet. 2006;38:682-687.
4. Dimitri P, Warner J, Minton JA, et al. Novel GLIS3 mutations demonstrate an extended multisystem phenotype. Eur J Endocrinol. 2011;164:437-443.
5. Goodarzi MO, Guo X, Cui J, et al. Systematic evaluation of validated type 2 diabetes and glycaemic trait loci for association with insulin clearance. Diabetologia. 2013;56:1282-1290.
6. Liu C, Li H, Qi L, et al. Variants in GLIS3 and CRY2 are associated with type 2 diabetes and impaired fasting glucose in Chinese Hans. PLoS One. 2011;6:21464.
7. Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42:105-116.
8. Rees SD, Hydrie MZ, O'Hare JP, et al. Effects of 16 genetic variants on fasting glucose and type 2 diabetes in South Asians: ADCY5 and GLIS3 variants may predispose to type 2 diabetes. PLoS One. 2011;6:e24710.
9. Cho YS, Chen CH, Hu C, et al. Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet. 2012;44:67-72.
10. Watanabe N, Hiramatsu K, Miyamoto R, et al. A murine model of neonatal diabetes mellitus in Glis3-deficient mice. FEBS Lett. 2009; 583:2108-2113.
11. Kang HS, Kim YS, ZeRuth G, et al. Transcription factor Glis3, a novel critical player in the regulation of pancreatic β-cell development. Mol Cell Biol. 2009;29:6366-6379.
12. Yang Y, Chang BH, Yechoor V, et al. The Krüppel-like zinc finger protein GLIS3 transactivates neurogenin 3 for proper fetal pancreatic islet differentiation in mice. Diabetologia. 2011;54:2595-2605.
13. Yang Y, Chang BH, Samson SL, Li MV, Chan L. The Krüppel-like zinc finger protein Glis3 directly and indirectly activates insulin gene transcription. Nucleic Acids Res. 2009;37:2529-2538.
14. Yang Y, Chang BH, Chan L. Sustained expression of the transcription factor GLIS3 is required for normal beta cell function in adults. EMBO Mol Med. 2013;5:92-104.
15. Andrali SS, Sampley ML, Vanderford NL, Ozcan S. Glucose regulation of insulin gene expression in pancreatic β-cells. Biochem J. 2008;415:1-10.
16. Melloul D, Marshak S, Cerasi E. Regulation of insulin gene transcription. Diabetologia. 2002;45:309-326.
17. Ohneda K, Ee H, German M. Regulation of insulin gene transcription. Semin Cell Dev Biol. 2000;11:227-233.
18. Sharma A, Moore M, Marcora E, et al. The NeuroD1/BETA2 sequences essential for insulin gene transcription colocalize with those necessary for neurogenesis and p300/CREB binding protein binding. Mol Cell Biol. 1999;19:704-713.
19. Qiu Y, Guo M, Huang S, Stein R. Insulin gene transcription is mediated by interactions between the p300 coactivator and PDX-1, BETA2, and E47. Mol Cell Biol. 2002;22:412-420.
20. Qiu Y, Sharma A, Stein R. p300 mediates transcriptional stimulation by the basic helix-loop-helix activators of the insulin gene. Mol Cell Biol. 1998;18:2957-2964.
21. Zhao L, Guo M, Matsuoka T, et al. The islet beta cell-enriched MafA activator is a key regulator of insulin gene transcription. J Biol Chem. 2005;280:11887-11894.
22. Cerf M. Transcription factors regulating beta-cell function. Eur J Endocrinol. 2006;155:671-679.
23. Ackermann AM, Gannon M. Molecular regulation of pancreatic beta-cell mass development, maintenance, and expansion. J Mol Endocrinol. 2007;38:193-206.
24. Beak JY, Kang HS, Kim YS, Jetten AM. Functional analysis of the zinc finger and activation domains of Glis3 and mutant Glis3(NDH1). Nucleic Acids Res. 2008;36:1690-1702.
25. ZeRuth GT, Yang XP, Jetten AM. Modulation of the transactivation function and stability of Krüppel-like zinc finger protein Glisimilar 3 (Glis3) by Suppressor of Fused. J Biol Chem. 2011;286: 22077-22089.
26. Docherty H, Hay CW, Ferguson LA, Barrow J, Durward E, Docherty K. Relative contribution of PDX-1, MafA and E47/β2 to the regulation of the human insulin promoter. Biochem J. 2005;389: 813-820.
27. German MS, Wang J, Chadwick RB, Rutter WJ. Synergistic activation of the insulin gene by a LIM-homeo domain protein and a basic helix-loop-helix protein: building a functional insulin minienhancer complex. Genes Dev. 1992;6:2165-2176.
28. Johnson JD, Zhang W, Rudnick A, Rutter WJ, German MS. Transcriptional synergy between LIM-homeodomain proteins and basic helix-loop-helix proteins: the LIM2 domain determines specificity. Mol Cell Biol. 1997;17:3488-3496.
29. Glick E, Leshkowitz D, Walker MD. Transcription factor BETA2 acts cooperatively with E2A and PDX1 to activate the insulin gene promoter. J Biol Chem. 2000;275:2199-2204.
30. Mutoh H, Naya FJ, Tsai MJ, Leiter AB. The basic helix-loop-helix protein BETA2 interacts with p300 to coordinate differentiation of secretin-expressing enteroendocrine cells. Genes Dev. 1998;12: 820-830.
31. Stanojevic V, Habener JF, Thomas MK. Pancreas duodenum homeobox-1 transcriptional activation requires interactions with p300. Endocrinology. 2004;145:2918-2928.
32. Chen Q, Dowhan DH, Liang D, Moore DD, Overbeek PA. CREBbinding protein/p300 co-activation of crystallin gene expression. J Biol Chem. 2002;277:24081-24089.
33. Arany Z, Newsome D, Oldread E, Livingston DM, Eckner R. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature. 1995;374:81-84.
34. Chakravarti D, Ogryzko V, Kao H, et al. A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell. 1999; 96:393-403.
35. Hamamori Y, Sartorelli V, Ogryzko V, et al. Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A. Cell. 1999;96:405-413.
36. Perissi V, Dasen JS, Kurokawa R, et al. Factor-specific modulation of CREB-binding protein acetyltransferase activity. Proc Natl Acad Sci USA. 1999;96:3652-3657.
37. Chan HM, La Thangue NB. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci. 2001;114:2363-2373.
38. Garin I, Edghill EL, Akerman I, et al. Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis. Proc Natl Acad Sci USA. 2010;107:3105-3110.
39. Kalkhoven E. CBP and p300: HATs for different occasions. Biochem Pharmacol. 2004;68:1145-1155.
40. Ikeda K, Stuehler T, Meisterernst M. The H1 and H2 regions of the activation domain of herpes simplex virion protein 16 stimulate transcription through distinct molecular mechanisms. Genes Cells. 2002;7:49-58.
41. Goodman RH, Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev. 2000;14:1553-1577.
42. Ohneda K, Mirmira RG, Wang J, Johnson JD, German MS. The homeodomain of PDX-1 mediates multiple protein-protein interactions in the formation of a transcriptional activation complex on the insulin promoter. Mol Cell Biol. 2000;20:900-911.
43. Morris AP, Voight BF, Teslovich TM, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44:981-990.
44. Li H, Gan W, Lu L, et al. A genome-wide association study identifies gRK5 and RASGRP1 as type 2 diabetes loci in Chinese Hans. Diabetes 2013;62:291-298.
45. Bonnefond A, Lomberk G, Buttar N, et al. Disruption of a novel Kruppel-like transcription factor p300-regulated pathway for insulin biosynthesis revealed by studies of the c.-331 INS Mutation found in neonatal diabetes mellitus. J Biol Chem. 2011;286: 28414-28424.